Login
Our latest news
-
Our experts respond to new study about continuing breast cancer risks after HRT
A study has found the risk of breast cancer when using hormone replacement therapy (HRT) is higher than previously thought and continues when HRT is stopped, prompting new information from the MHRA. However, our experts say that HRT still has an important role to play in osteoporosis care.
-
Our thoughts on the new biosimilars for osteoporosis available on the NHS
Two new biosimilars have been launched for the osteoporosis medication teriparatide. This is positive news that we hope will improve access to the treatment across the UK.
-
Osteoporosis support group leaves a lasting legacy
Our former Borders support group has raised more than £2,000 for local healthcare services.
-
Our advice following reports of HRT shortages
You may have read in the news about shortages of hormone replacement therapy (HRT). If you’re taking HRT for osteoporosis, you shouldn’t need to worry.
-
Chief Executive Claire Severgnini announces retirement
Chief Executive Claire Severgnini has announced she is retiring from the Royal Osteoporosis Society at the end of this year.
